文献速递主动脉疾病静脉血栓栓塞

主动脉腔内修复术后肺栓塞:一项回顾性队列研究

Pulmonary Embolism After Endovascular Aortic Repair, a Retrospective Cohort Study.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2018-10-20

该单中心回顾性队列研究纳入2010年1月至2015年7月在乌得勒支大学医学中心接受EVAR且术后1个月内完成主动脉、胸主动脉或肺动脉CTA的成年患者,分析EVAR术后肺栓塞发生率及其与死亡率的关系。74例手术(40例胸主动脉EVAR、34例腹主动脉EVAR)中9例(12%,95%CI 7-22)发现肺栓塞,其中7例无症状,肺栓塞患者30天死亡率显著更高(相对风险14.4,95%CI 1.4-143,p=.037),但无死亡直接归因于肺栓塞。

要点

  • EVAR术后1个月内肺栓塞发生率为12%(95%CI 7-22),多数为亚段且临床无症状。
  • 肺栓塞患者30天死亡率显著更高(相对风险14.4,95%CI 1.4-143,p=.037)。
  • 尽管常规血栓栓塞预防,无症状肺栓塞仍约每10例EVAR中发生1例。

核心结论

  • 该研究虽为初步研究,但提示EVAR术后无症状肺栓塞约每10例患者中发生1例,尽管已进行常规血栓栓塞预防。
  • 肺栓塞与更高的30天死亡风险相关,但在这些患者中肺栓塞并非任何一例的死亡原因。

研究设计与样本

  • 单中心回顾性队列研究,纳入2010年1月至2015年7月在乌得勒支大学医学中心接受EVAR且术后1个月内完成全主动脉、胸主动脉或肺动脉CTA的成年患者。
  • 研究期间共施行526例EVAR,其中74例纳入分析,包括40例胸主动脉EVAR和34例腹主动脉EVAR。
  • 基线及死亡数据通过查阅医院和全科医生记录获得,主要结局为术后1个月内肺栓塞,次要结局为30天和6个月死亡率。

主要发现

  • 9例患者(12%,95%CI 7-22)观察到肺栓塞,其中1例为中心型、2例为段型、6例为亚段型。
  • 9例肺栓塞中7例临床无症状,2例在术前CTA上已存在。
  • 肺栓塞患者30天死亡率显著更高(相对风险14.4,95%CI 1.4-143,p=.037),但无死亡似乎直接归因于肺栓塞。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文自述该研究为初步研究(preliminary)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Endovascular aortic repair (EVAR) is associated with an increased risk of pulmonary embolism, which is often clinically silent and therefore difficult to recognise. The aim was to investigate the incidence of pulmonary embolism after EVAR using routinely performed pre- and post-operative aortic computed tomography angiography (CTA), and the association between pulmonary embolism and mortality. METHODS: This single centre retrospective cohort study included adult patients who underwent EVAR in the University Medical Centre Utrecht between January 2010 and July 2015 and who had a total aortic, thoracic aortic, or pulmonary CTA within one month post-operatively. Baseline and mortality data were obtained by reviewing hospital and general practitioner records. The primary outcome was pulmonary embolism within one month after surgery. Secondary outcomes were 30 day and six month mortality. RESULTS: During the study period, 526 EVARs were performed. Seventy-four of these procedures were included in the analysis of which there were 40 thoracic and 34 abdominal EVARs. In nine patients (12%, 95% CI 7-22) pulmonary embolism was observed of which one was central, two were segmental, and six were subsegmental. Seven were clinically silent and two were present on the pre-operative CTA. Thirty day mortality was significantly higher in patients with pulmonary embolism (relative risk 14.4, 95% CI 1.4-143, p = .037) though none of the deaths seemed directly attributable to it. CONCLUSIONS: This study, although preliminary, suggests that silent pulmonary embolism after EVAR occurs in approximately one in 10 patients, despite routine thrombo-embolism prophylaxis. Pulmonary embolism was associated with a higher 30 day mortality risk yet it was not the cause of death in any of these patients.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Grobben RB, Frima C, Nathoe HM, et al. Pulmonary Embolism After Endovascular Aortic Repair, a Retrospective Cohort Study. Eur J Vasc Endovasc Surg. 2018. PMID: 30348482. doi:10.1016/j.ejvs.2018.08.054

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。